Skip to main content
ES
v1.2
Log in
N

Natco Pharma

NATCO PHARMANSE
₹789+0.00 (+0.00%)
Market Cap
₹15,419Cr.
P/E Ratio
13.5
P/B Ratio
1.68
EPS (TTM)
₹58.44
Div Yield
0.63%
ROCE
17.4%
ROE
17.1%
52W Low: ₹77952W High: ₹1,227
Themes:💊 Pharma & CDMO
Appears in 1 screen
⬇️52-Week Low Watch
91
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 15.0% a year over three years.
  • Debt is 0.08× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Natco_Pharma — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Upper third
7.5/ 10Overall
9/ 10Valuation
7/ 10Quality
7/ 10Fundamental
7/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 13.5P/E: 13.5 | P/B: 1.68
Growth
GrowingSales CAGR — 3Y: 15% · 1Y: -21%
Profitability
ModerateROCE: 17.4% | ROE: 17.1%

Key Metrics

Valuation
PEG Ratio 0.50
Price / Sales 4.42x
Price / FCF 11.2x
Book Value ₹470
Margins & returns
Operating Margin 30%

Frequently Asked Questions

MarketsPortfolioChart